72 related articles for article (PubMed ID: 20167269)
1. The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing.
Haglund C; Aleskog A; Håkansson LD; Höglund M; Jacobsson S; Larsson R; Lindhagen E
Toxicol Lett; 2010 May; 194(3):102-7. PubMed ID: 20167269
[TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of granulo-monocytic progenitors as a new toxicological cell system and endpoint in the ACuteTox Project.
Cerrato L; Valeri A; Bueren JA; Albella B
Toxicol Appl Pharmacol; 2009 Jul; 238(2):111-9. PubMed ID: 19442680
[TBL] [Abstract][Full Text] [Related]
3. Study of early hematopoietic precursors in human cord blood.
Abboud M; Xu F; LaVia M; Laver J
Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
[TBL] [Abstract][Full Text] [Related]
4. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
van de Ven C; Ishizawa L; Law P; Cairo MS
Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csoka K; Larsson R; Tholander B; Gerdin E; de la Torre M; Nygren P
Gynecol Oncol; 1994 Aug; 54(2):163-70. PubMed ID: 7520407
[TBL] [Abstract][Full Text] [Related]
6. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method.
Malerba I; Casati S; Diodovich C; Parent-Massin D; Gribaldo L
Toxicol In Vitro; 2004 Jun; 18(3):293-300. PubMed ID: 15046776
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.
Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D
Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.
Goff JP; Shields DS; Boggs SS; Greenberger JS
Radiat Res; 1997 Jan; 147(1):61-9. PubMed ID: 8989371
[TBL] [Abstract][Full Text] [Related]
10. Growth factors increase retroviral transduction but decrease clonogenic potential of umbilical cord blood CD34+ cells.
Corrias MV; Scuderi F; Pasino M; Biglino P; Bocca P; Marotta F; Figini E; Pistoia V; Mori PG
Haematologica; 1998 Jul; 83(7):580-6. PubMed ID: 9718861
[TBL] [Abstract][Full Text] [Related]
11. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.
Pessina A; Albella B; Bayo M; Bueren J; Brantom P; Casati S; Croera C; Gagliardi G; Foti P; Parchment R; Parent-Massin D; Schoeters G; Sibiril Y; Van Den Heuvel R; Gribaldo L
Toxicol Sci; 2003 Oct; 75(2):355-67. PubMed ID: 12883091
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
13. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
14. Human CD34(+) progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicity.
Guo L; Hamre J; Davis M; Parchment RE
Toxicol In Vitro; 2016 Mar; 31():103-13. PubMed ID: 26616282
[TBL] [Abstract][Full Text] [Related]
15. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
16. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
19. New method for stem cell quantification: applications to the management of peripheral blood stem cell transplantation.
Legros M; Fleury J; Curé H; Condat P; Lenat A; Subtil E; Sanderson D; Communal Y; Basile M; Tavernier F
Bone Marrow Transplant; 1995 Jan; 15(1):1-8. PubMed ID: 7537997
[TBL] [Abstract][Full Text] [Related]
20. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]